# GEBT Lot-to-Lot and Biological Variability

> **NCT04772261** · NA · COMPLETED · sponsor: **Cairn Diagnostics** · enrollment: 21 (actual)

## Conditions studied

- Gastroparesis

## Interventions

- **DIAGNOSTIC_TEST:** 13C-Spirulina GEBT

## Key facts

- **NCT ID:** NCT04772261
- **Lead sponsor:** Cairn Diagnostics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-05
- **Primary completion:** 2022-01-10
- **Final completion:** 2022-01-10
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2022-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04772261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04772261, "GEBT Lot-to-Lot and Biological Variability". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04772261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*